FOXA1 index ≥1% was also negatively correlated with lymphovascular invasion, including in triple-negative FMCs, as sometimes reported in breast cancer: Albergaria et al. (2009) found that 37% (30/81) of FOXA1-positive breast cancers were LVI+ compared to 55% (67/122) of FOXA1-negative carcinomas [56]. The gene discussed is FOXA1; the disease is breast cancer.